EUVIMEDEUVIMED entdecken
Vergleichsstudie

Blue laser turbinate reduction with vs. without posterior nasal neurolysis for refractory rhinitis: a retrospective comparative study

Cheng-Jung Wu, Sheng-Yu Wu, Cheng-Yu Tsai, Arnab Majumdar, Jeffrey Yang, Jinn-Moon Yang, Lok-Yee Joyce Li

European Archives of Oto-Rhino-Laryngology · 2026-07 · 283 (7) · 4485-4491

DOI: 10.1007/s00405-026-10271-3 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 15.06.2026. Verfasst von Cheng-Jung Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Turbinates, Rhinitis, Nasal Obstruction, Laser Therapy. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Taipei Medical University, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Chronic rhinitis that does not respond well to drug therapy remains a major challenge in clinical treatment. Inferior turbinate reduction can improve nasal obstruction symptoms, while posterior nasal nerve (PNN) ablation can reduce symptoms caused by neurogenic hypersecretion. Blue laser technology provides precise tissue coagulation and minimizes intraoperative bleeding. METHODS: This retrospective comparative study, conducted at Shuang Ho Hospital between 2024 and 2025, aimed to compare the efficacy and safety of blue laser inferior turbinate reduction (BITR) combined with blue laser posterior nasal nerve neurolysis (BPN3) versus BITR alone. A total of Ninety-nine adult patients with chronic rhinitis who had not responded adequately to at least three months of drug therapy (≥ 3 months) were included. Among them, forty-eight patients received BITR combined with BPN3, and fifty-one patients received BITR only. The primary endpoints were the 24-hour reflective total nasal symptoms score (rTNSS) and the nasal obstruction symptoms evaluation scale (NOSE) score, which were compared and analyzed at baseline, 1 month and 6 months postoperatively. RESULTS: At 6 months post-surgery, the mean Responsive Total Nasal Symptom Score (rTNSS) decreased by 77.6% in the BITR combined with BPN3 group (from 7.6 ± 1.9 to 1.7 ± 1.6), while the BITR alone group saw a 48% decrease (from 7.5 ± 1.6 to 3.9 ± 1.7), with a statistically significant difference between the two groups (p < 0.05). The Nasal Obstruction Symptom Assessment Scale (NOSE) scores improved by 91.9% and 85.5%, respectively, with a statistically significant difference between the two groups (p < 0.05). Overall, no serious complications occurred during the study period. CONCLUSION: Blue laser posterior nasal nerve neurolysis combined with inferior turbinate reduction provides superior symptom relief compared with BITR alone, particularly for rhinorrhea, with excellent safety and tolerability. This dual-target approach offers a promising minimally invasive treatment for medication-refractory chronic rhinitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TurbinatesRhinitisNasal ObstructionLaser TherapyNerve BlockHumansRetrospective StudiesFemaleMaleAdultMiddle AgedChronic DiseaseTreatment OutcomeCombined Modality Therapy

Stichwörter der Autor:innen

Blue laserChronic rhinitisNeurolysisPosterior nasal nerveTurbinate reductionrTNSS

Autor:innen und Institutionen

  • Department of Otolaryngology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
  • Department of Otolaryngology, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan.
  • Ph.D. Degree Program of Biomedical Science and Engineering, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
  • Allergy and Rhinology Center, Quality Health Care Center, Taoyuan, Taiwan.
  • Department of Industrial Engineering and Industrial Management, National Tsing Hua University, Hsinchu, Taiwan.
  • Department of Civil and Environmental Engineering, Imperial College London, London, UK.

Förderung

  • Taipei Medical University
  • National Science and Technology Council

Zitieren

APA

Wu, C. J., Wu, S. Y., Tsai, C. Y., Majumdar, A., Yang, J., Yang, J. M., & Li, L. J. (2026). Blue laser turbinate reduction with vs. without posterior nasal neurolysis for refractory rhinitis: a retrospective comparative study. European Archives of Oto-Rhino-Laryngology, 283(7), 4485-4491. https://doi.org/10.1007/s00405-026-10271-3

Vancouver

Wu CJ, Wu SY, Tsai CY, Majumdar A, Yang J, Yang JM, et al. Blue laser turbinate reduction with vs. without posterior nasal neurolysis for refractory rhinitis: a retrospective comparative study. European Archives of Oto-Rhino-Laryngology. 2026;283(7):4485-4491. doi:10.1007/s00405-026-10271-3

BibTeX
@article{Wu2026,
  author = {Wu, Cheng-Jung and Wu, Sheng-Yu and Tsai, Cheng-Yu and Majumdar, Arnab and Yang, Jeffrey and Yang, Jinn-Moon and Li, Lok-Yee Joyce},
  title = {Blue laser turbinate reduction with vs. without posterior nasal neurolysis for refractory rhinitis: a retrospective comparative study},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2026},
  volume = {283},
  number = {7},
  pages = {4485--4491},
  doi = {10.1007/s00405-026-10271-3}
}
Kostenlos starten →